COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 159 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $967,000 | +10.5% | 43,250 | +6.2% | 0.00% | – |
| Q2 2023 | $875,000 | +16.2% | 40,731 | +29.6% | 0.00% | – |
| Q1 2023 | $753,000 | +50.6% | 31,422 | +45.9% | 0.00% | – |
| Q4 2022 | $500,000 | +67.2% | 21,541 | +15.7% | 0.00% | – |
| Q3 2022 | $299,000 | +10.7% | 18,624 | +21.8% | 0.00% | – |
| Q2 2022 | $270,000 | -9.7% | 15,295 | +4.0% | 0.00% | – |
| Q1 2022 | $299,000 | +147.1% | 14,701 | +126.3% | 0.00% | – |
| Q4 2021 | $121,000 | +68.1% | 6,495 | +78.1% | 0.00% | – |
| Q3 2021 | $72,000 | -2.7% | 3,647 | +17.3% | 0.00% | – |
| Q2 2021 | $74,000 | +335.3% | 3,110 | +344.3% | 0.00% | – |
| Q1 2021 | $17,000 | -37.0% | 700 | -47.8% | 0.00% | – |
| Q4 2020 | $27,000 | -43.8% | 1,340 | -41.7% | 0.00% | – |
| Q3 2020 | $48,000 | -66.9% | 2,300 | -72.2% | 0.00% | – |
| Q2 2020 | $145,000 | -31.9% | 8,275 | -36.4% | 0.00% | – |
| Q1 2020 | $213,000 | -53.9% | 13,019 | -41.9% | 0.00% | – |
| Q4 2019 | $462,000 | +87.8% | 22,416 | +4.5% | 0.00% | – |
| Q3 2019 | $246,000 | +8.4% | 21,450 | +24.2% | 0.00% | – |
| Q2 2019 | $227,000 | +15.8% | 17,275 | +33.7% | 0.00% | – |
| Q1 2019 | $196,000 | -47.5% | 12,925 | -40.4% | 0.00% | – |
| Q4 2018 | $373,000 | -5.1% | 21,676 | -18.7% | 0.00% | – |
| Q3 2018 | $393,000 | -2.5% | 26,664 | +57.5% | 0.00% | – |
| Q2 2018 | $403,000 | -44.1% | 16,926 | -40.1% | 0.00% | – |
| Q1 2018 | $721,000 | +51.5% | 28,238 | +9.4% | 0.00% | – |
| Q4 2017 | $476,000 | +59.7% | 25,801 | -9.2% | 0.00% | – |
| Q3 2017 | $298,000 | -18.4% | 28,429 | -2.4% | 0.00% | – |
| Q2 2017 | $365,000 | +39.8% | 29,139 | +12.7% | 0.00% | – |
| Q1 2017 | $261,000 | -16.3% | 25,854 | +28.8% | 0.00% | – |
| Q4 2016 | $312,000 | +5.4% | 20,070 | +30.7% | 0.00% | – |
| Q3 2016 | $296,000 | +116.1% | 15,350 | +32.3% | 0.00% | – |
| Q2 2016 | $137,000 | -33.2% | 11,600 | +2.7% | 0.00% | – |
| Q1 2016 | $205,000 | +485.7% | 11,300 | +794.0% | 0.00% | – |
| Q4 2015 | $35,000 | +400.0% | 1,264 | +322.7% | 0.00% | – |
| Q3 2015 | $7,000 | -12.5% | 299 | -33.8% | 0.00% | – |
| Q2 2015 | $8,000 | – | 452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
| Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
| Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
| GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
| RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
| Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
| CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
| EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
| ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |